The President of the Swiss Federal Institute of Technology Lausanne EPFL, the Dean of the EPFL School of Life Sciences, and the Executive Board of Debiopharm Group are pleased to invite applications for
2 Junior Debiopharm Group Life Sciences Awards 2013
The Sponsor, Debiopharm Group™, is a Swiss biopharmaceutical company with a focus on the development of innovative therapies that target unmet medical needs.
The awards will honor two young researchers (at the advanced postdoc or early junior group leader stage) under the age of 33 working at a Swiss institution in the wider area of
Cellular and molecular biology.
This includes, but is not limited to cancer, genetics, signal transduction, infection biology, developmental biology, and neuroscience.
The awards consist of a total of 25’000 CHF each, of which one fifth is a personal award, while the rest will contribute to support the awardee’s research. It will be presented at the Annual EPFL Life Science Symposium on this year’s theme “Motor control – from neural circuits and diseases to neuroprosthetics” to be held 28-30 August 2013.
Candidates are invited to submit their applications no later than April 15th, 2013. A Jury of internationally renowned scientific experts will evaluate the applications, and invite preselected candidates to the EPFL for a short presentation. The dossier should be comprised of:
- her/his curriculum vitae,
- her/his list of publications,
- a one-page outline of her/his plans for future research and career,
- names and contact details of two reference persons.
more info: link